Industry Supports Device Development Tools, But Says: Show Me The Money
This article was originally published in The Gray Sheet
Executive Summary
Industry is skeptical of FDA’s medical device development tools program draft guidance, which establishes a voluntary process to validate publicly available device development tools so companies can freely share the tools in a pre-competitive space.